While the role of activated Wnt/β-Catenin signaling in prostate cancer is not entirely clear, recent evidence indicates that β-Catenin contributes to prostate cancer progression through its enhancement of the AR transcriptional activity in the presence of androgens [13]. The gene discussed is AR; the disease is prostate carcinoma.